Mold hysteria: Origin of the hoax

Clinical and Developmental Immunology

Volumn 12, Issue 2, 2005, Pages 151-158

  Chang, Christopher ^a   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Allergies; Asthma; Hypersensitivity pneumonitis; Mold

Indexed keywords

HOUSE DUST ALLERGEN; MYCOTOXIN; POLLEN ANTIGEN;

ACTINOBACTERIA; AIR CONDITIONING; AIR POLLUTION; AIR QUALITY; ALLERGIC PNEUMONITIS; ALTERNARIA; ALTERNARIA ALTERNATA; AMBIENT AIR; ARTICLE; ASPERGILLUS FUMIGATUS; CAT; CLADOSPORIUM; CLADOSPORIUM HERBARUM; CLINICAL FEATURE; COCKROACH; DOG; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL SANITATION; GRASS POLLEN; HUMAN; IMMUNOASSAY; LAW; LEGIONELLA; LEGIONELLA PNEUMONIAE; LEGIONNAIRE DISEASE; LUNG ASPERGILLOSIS; MEDICAL PERSONNEL; MICROBIAL CONTAMINATION; MOULD; MYCOSIS; NONHUMAN; OCCUPATIONAL DISEASE; PNEUMONIA; PRIORITY JOURNAL; SACCHAROPOLYSPORA RECTIVIRGULA; SICK BUILDING SYNDROME; SKIN TEST; STACHYBOTRYS; TOXIC MOLD SYNDROME; WORK ENVIRONMENT; WORKROOM AIR; COMPENSATION; FUNGUS; HISTORY; UNITED STATES;

COMPENSATION AND REDRESS; FUNGI; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; LEGIONNAIRES' DISEASE; MYCOSES; UNITED STATES;

EID: 24744469888     PISSN: 17402522     EISSN: None     Source Type: Journal    
DOI: 10.1080/17402520500131409     Document Type: Article

References (49)

1. Anyanwu EC, Campbell AW, Ehiri JE. 2004. Mycotoxins and antifungal drug interactions: Implications in the treatment of illnesses due to indoor chronic toxigenic mold exposures. Scientific World J 4:167-177.
2. Assoulin-Daya Y, Leong A, Shoenfeld Y, Gershwin ME. 2002. Studies of sick building syndrome. IV. Mycotoxicosis. J Asthma 39(3):191-201.
3. Barrett JR. 2003. Mold insurance: Crafting coverage for a spreading problem. Environ Health Perspect 111(2):A100-A103.
4. Bennett JW. 1987. Mycotoxins, mycotoxicoses, mycotoxicology and mycopathologia. Mycopathologia 100(1):3-5.
5. Bobbitt Jr, RC, Crandall MS, Venkataraman A, Bernstein JA. 2005. Characterization of a population presenting with suspected mold-related health effects. Ann Allergy Asthma Immunol 94(1):39-44.
6. Chang C, Gershwin ME. 2004. Indoor air quality and human health: Truth vs mass hysteria. Clin Rev Allergy Immunol 27(3):219-240.
7. Chang CC, Ruhl RA, Halpern GM, Gershwin ME. 1993. The sick building syndrome. I. Definition and epidemiological considerations. J Asthma 30(4):285-295.
8. Chang CC, Ruhl RA, Halpern GM, Gershwin ME. 1994. Building components contributors of the sick building syndrome. J Asthma 31(2):127-137.
9. Chapman JA, Terr AI, Jacobs RL, Charlesworth EN, Bardana Jr, EJ. 2003. Toxic mold: Phantom risk vs science. Ann Allergy Asthma Immunol 91(3):222-232.
10. Coop C, England RW, Quinn JM. 2004. Allergic broncho-pulmonary aspergillosis masquerading as invasive pulmonary aspergillosis. Allergy Asthma Proc. 25(4):263-266.
11. Crain EF, Walter M, O'Connor GT, et al. 2002. Home and allergic characteristics of children with asthma in seven U.S. urban communities and design of an environmental intervention: The Inner-City Asthma Study. Environ Health Perspect 110(9):939-945.
12. Edmondson DA, Nordness ME, Zacharisen MC, Kurup VP, Fink JN. 2005. Allergy and "toxic mold syndrome". Ann Allergy Asthma Immunol 94(2):234-239.
13. Ehrlich KC, Daigle KW 1987. Protein synthesis inhibition by 8-oxo-12,13-epoxytrichothecenes. Biochim Biophys Acta 923(2):206-213.
14. Etzel RA. 2003. Stachybotrys. Curr Opin Pediatr 15(1): 103-106.
15. Etzel RA, Montana E, Sorenson WG, et al. 1998. Acute pulmonary hemorrhage in infants associated with exposure to Stachybotrys atra and other fungi. Arch Pediatr Adolesc Med 152(8):757-762.
16. Greenberger PA. 2004. Mold-induced hypersensitivity pneumonitis. Allergy Asthma Proc 25(4):219-223.
17. Gruchalla RS, Pongracic J, Plaut M, et al. 2005. Inner city asthma study: Relationships among sensitivity, allergen exposure, and asthma morbidity. J Allergy Clin Immunol 115(3):478-485.
18. Hardin BD, Kelman BJ, Saxon A. 2003. Adverse human health effects associated with molds in the indoor environment. J Occup Environ Med 45(5):470-478.
19. Havaux X, Zeine A, Dits A, Denis O. 2005. A new mouse model of lung allergy induced by the spores of Alternaria alternate and Cladosporium herbarum molds. Clin Exp Immunol 139(2):179-188.
20. Jarvis BB, Miller JD. 2005. Mycotoxins as harmful indoor air contaminants. Appl Microbiol Biotechnol 66(4):367-372.
21. Kelman BJ, Robbins CA, Swenson LJ, Hardin BD. 2004. Risk from inhaled mycotoxins in indoor office and residential environments. Int J Toxicol 23(1):3-10.
22. Kuhn DM, Ghannoum MA. 2003. Indoor mold, toxigenic fungi, and Stachybotrys chartarum: Infectious disease perspective. Clin Microbiol Rev 16(1):144-172.
23. Lee MG, Li S, Jarvis BB, Pestka JJ. 1999. Effects of satratoxins and other macrocyclic trichothecenes on IL-2 production and viability of EL-4 thymoma cells. J Toxicol Environ Health A 57(7):459-474.
24. Lees-Haley PR. 2003. Toxic mold and mycotoxins in neurotoxicity cases: Stachybotrys, Fusarium, Trichoderma, Aspergillus, Penicillium, Cladosporium, Alternaria, Trichothecenes. Psychol Rep 93(2):561-584.
25. Luong A, Marple BF. 2004. Allergic fungal rhinosinusitis. Curr Allergy Asthma Rep 4(6):465-470.
26. Mahmoudi M, Gershwin ME. 2000. Sick building syndrome. III. Stachybotrys chartarum. J Asthma 37(2):191-198.
27. Malde B, Greenberger PA. 2004. Allergic bronchopulmonary aspergillosis. Allergy Asthma Proc 25(4 Suppl. 1):S38-S39.
28. Marras TK, Wallace Jr. RJ, Koth LL, Stulbarg MS, Cowl CT, Daley CL. 2005. Hypersensitivity pneumonitis reaction to Mycobacterium avium in household water. Chest 127(2):664-671.
29. Mason CD, Rand TG, Oulton M, MacDonald J, Anthes M. 2001. Effects of Stachybotrys chartarum on surfactant convertase activity in juvenile mice. Toxicol Appl Pharmacol 172(1):21-28.
30. Moore JE, Convery RP, Millar BC, Rao JR, Elborn JS. 2005. Hypersensitivity pneumonitis associated with mushroom worker's lung: An update on the clinical significance of the importation of exotic mushroom varieties. Int Arch Allergy Immunol 136(1):98-102.
31. Morgan WJ, Crain EF, Gruchalla RS, et al. 2004. Results of a home-based environmental intervention among urban children with asthma. N Engl J Med 351(11):1068-1080.
32. Nacar N, Kiper N, Yalcin E, et al. 2004. Hypersensitivity pneumonitis in children: Pigeon breeder's disease. Ann Trop Paediatr 24(4):349-355.
33. Nagase M, Alam MM, Tsushima A, Yoshizawa T, Sakato N. 2001. Apoptosis induction by T-2 toxin: Activation of caspase-9, caspase-3, and DFF-40/CAD through cytosolic release of cytochrome c in HL-60 cells. Biosci Biotechnol Biochem 65(8):1741-1747.
34. Nordness ME, Zacharisen MC, Fink JN. 2003. Toxic and other non-IgE-mediated effects of fungal exposures. Curr Allergy Asthma Rep 3(5):438-446.
35. O'Connor GT, Walter M, Mitchell H, et al. 2004. Airborne fungi in the homes of children with asthma in low-income urban communities: The Inner-City Asthma Study. J Allergy Clin Immunol 114(3):599-606.
36. Ohnishi H, Yokoyama A, Hamada H, et al. 2002. Humidifier lung: Possible contribution of endotoxin-induced lung injury. Intern Med 41(12):1179-1182.
37. O'Mahony M, Lakhani A, Stephens A, Wallace JG, Youngs ER, Harper D. 1989. Legionnaires' disease and the sick-building syndrome. Epidemiol Infect 103(2):285-292.
38. Pal TM, de Monchy JG, Groothoff JW, Post D. 1997. The clinical spectrum of humidifier disease in synthetic fiber plants. Am J Ind Med 31(6):682-692.
39. Robbins CA, Swenson LJ, Nealley ML, Gots RE, Kelman BJ. 2000. Health effects of mycotoxins in indoor air: A critical review. Appl Occup Environ Hyg 15(10):773-784.
40. Ryu JC, Ohtsubo K, Izumiyama N, Mori M, Tanaka T, Ueno Y. 1987. Effects of nivalenol on the bone marrow in mice. J Toxicol Sci 12(1):11-21.
41. Slavin RG, Hutcheson PS, Chauhan B, Bellone CJ. 2004. An overview of allergic bronchopulmonary aspergillosis with some new insights. Allergy Asthma Proc 25(6):395-399.
42. Terr AI. 2001. Stachybotrys: Relevance to human disease. Ann Allergy Asthma Immunol 87(6 Suppl. 3):57-63.
43. Terr AI. 2004. Are indoor molds causing a new disease? J Allergy Clin Immunol 113(2):221-226.
44. Tsai YJ, Gershwin ME. 2002. The sick building syndrome: What is it when it is? Compr Ther 28(2):140-144.
45. Ueno Y, Fukushima K. 1968. Inhibition of protein and DNA syntheses in Ehrlich ascites tumour by nivalenol, a toxic principle of Fusarium nivale-growing rice. Experientia 24(10):1032-1033.
46. Ueno Y, Hosoya M, Morita Y, Ueno I, Tatsuno T. 1968. Inhibition of the protein synthesis in rabbit reticulocyte by nivalenol, a toxic principle isolated from Fusarium nivale-growing rice. J Biochem (Tokyo) 64(4):479-485.
47. Ueno Y, Lee US, Tanaka T, Hasegawa A, Matsuki Y. 1986. Examination of Chinese and U.S.S.R. cereals for the Fusarium mycotoxins, nivalenol, deoxynivalenol and zearalenone. Toxicon 24(6):618-621.
48. 1997. Update: Pulmonary hemorrhage/hemosiderosis among infants - Cleveland, Ohio, 1993-1996. MMWR Morb Mortal Wkly Rep 46(2):33-35.
49. Wark P. 2004. Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence-based review of azoles in treatment. Respir Med 98(10):915-923.